We have tools to #prevent #RSV complications in #infants; let's make these #available #globally!
--
#MaternalVaccine #MonoclonalAntibody
#Access #Equity #Affordability #Health

“Reliable data and coordinated partnerships are key”: PROTECT brings together immunisation stakeholders in Kenya — PROTECT On 26 February, Aga Khan University, a PROTECT partner, hosted a stakeholder engagement event in Nairobi, convening leaders in maternal health to strengthen collaboration and define actionable next st...

Proud to have coordinated the Kenya #PROTECTnetwork Stakeholders’ Forum 🇰🇪. Bringing together government, researchers, regulators & clinicians to strengthen #MaternalVaccine readiness.

Learn more: tinyurl.com/5x4nrr5h @globalhealthedctp3.bsky.social @linq-management.bsky.social

PROTECT team in Uganda emphasise the importance of maternal immunisation in a meeting with the Ministry of Health — PROTECT On 26 November 2025 the MU-JHU team met with the leadership of the Ministry of Health of Uganda to update them on ongoing work across all PROTECT work packages and to discuss strategies for strengthen...

🫱🏽‍🫲🏾Collaboration is at the heart of #PROTECTnetwork’s activities, ensuring that all key stakeholders are working together to advance #MaternalVaccine readiness.

Learn more about a recent meeting with the Ministry of Health of Uganda➡️ tinyurl.com/3rfj3d8h

@globalhealthedctp3.bsky.social

Maternal vaccine and nirsevimab cut RSV hospitalizations

A maternal RSV vaccine given during pregnancy and the monoclonal antibody nirsevimab have been shown to cut RSV hospitalizations in infants, according to recent data. Read more: getnews.me/maternal-vaccine-and-nir... #rsv #maternalvaccine #nirsevimab